Abstract
We propose TetraHer, a method for estimating the liability heritability of binary phenotypes. TetraHer has five key features. Firstly, it can be applied to data from complex pedigrees, that contain multiple types of relationships. Secondly, it can correct for ascertainment of cases or controls. Thirdly, it can accommodate covariates. Fourthly, it can model the contribution of common environment. Fifthly, it produces a likelihood, that can be used for significance testing. We first demonstrate the validity of TetraHer on simulated data. We then use TetraHer to estimate liability heritability for 229 codes from the tenth International Classification of Diseases (ICD-10). We identify 118 codes with significant heritability (P<0.05/229), which can be used in future analyses for investigating the genetic architecture of human diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
D.S. is supported by the Aarhus University Research Foundation (AUFF) and by the Independent Research Fund Denmark (project no. 7025-00094B). D.M.E. is supported by an NHMRC Investigator Grant (application ID 2017942).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at UK Biobank. You can apply for and download the data from https://www.ukbiobank.ac.uk
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The study used ONLY openly available human data that were originally located at UK Biobank. You can apply for and download the data from https://www.ukbiobank.ac.uk
